First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent

EuroIntervention

Volumn 6, Issue 1, 2010, Pages 46-53

  Ormiston, John A ^a   Lefèvre, Thierry ^b   Grube, Eberhard ^c   Allocco, Dominic J ^d   Dawkins, Keith D ^d  

^a Mercy Hospital   (New Zealand)

^b INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^c HELIOS Heart Center   (Germany)

^d BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Bifurcation; Coronary restenosis; Drug eluting stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; TICLOPIDINE; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; DRUG SAFETY; FAMILY HISTORY; FEASIBILITY STUDY; FEMALE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; Q WAVE; RIGHT CORONARY ARTERY; RISK FACTOR; SMOKING; STENT THROMBOSIS; AGED; ANGIOCARDIOGRAPHY; ENDOSCOPIC ECHOGRAPHY; EUROPE; INSTRUMENTATION; MIDDLE AGED; MORTALITY; NEW ZEALAND; PROSPECTIVE STUDY; PROSTHESIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; EUROPE; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW ZEALAND; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77956163642     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I1A8     Document Type: Article

References (20)

1. Stankovic G, Darremont O, Ferenc M, Hildick-Smith D, Louvard Y, Albiero R, Pan M, Lassen JF, Lefevre T. Percutaneous coronary intervention for bifurcation lesions: 2008 consensus document from the fourth meeting of the European Bifurcation Club. EuroIntervention. 2009;5:39-49.
2. Latib A, Colombo A. Bifurcation disease: what do we know, what should we do? JACC Cardiovasc Interv. 2008;1:218-26.
3. Thuesen L, Kelbaek H, Klovgaard L, Helqvist S, Jorgensen E, Aljabbari S, Krusell LR, Jensen GV, Botker HE, Saunamaki K, Lassen JF, van Weert A. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT). Am Heart J. 2006;152:1140-5. (Pubitemid 44872987)
4. Latib A, Colombo A, Sangiorgi GM. Bifurcation stenting: current strategies and new devices. Heart. 2009;95:495-504.
5. Johnson TW, Kay IP, Ormiston JA. A novel paclitaxel-eluting dedicated bifurcation stent: a case report from the first human use Taxus Petal trial. Catheter Cardiovasc Interv. 2009;73:637-40.
6. Ormiston J, Webster M, El-Jack S, McNab D, Plaumann SS. The AST petal dedicated bifurcation stent: first-in-human experience. Catheter Cardiovasc Interv. 2007;70:335-40. (Pubitemid 350194978)
7. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME. Randomized study to assess the effectiveness of slow- and moderaterelease polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788-94. (Pubitemid 37022118)
8. Lansky A, Tuinenburg J, Costa M, Maeng M, Koning G, Popma J, Cristea E, Gavit L, Costa R, Rares A, Van Es GA, Lefevre T, Reiber H, Louvard Y, Morice MC. Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation Group. Catheter Cardiovasc Interv. 2009;73:258-66.
9. Grube E, Buellesfeld L, Neumann FJ, Verheye S, Abizaid A, McClean D, Mueller R, Lansky A, Mehran R, Costa R, Gerckens U, Trauthen B, Fitzgerald PJ. Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. Am J Cardiol. 2007;99:1691-7. (Pubitemid 46881145)
10. Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ. 9- month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study. J Am Coll Cardiol. 2009;53:1031-9.
11. Colombo A, Bramucci E, Sacca S, Violini R, Lettieri C, Zanini R, Sheiban I, Paloscia L, Grube E, Schofer J, Bolognese L, Orlandi M, Niccoli G, Latib A, Airoldi F. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. Circulation. 2009;119:71-8.
12. Ferenc M, Gick M, Kienzle RP, Bestehorn HP, Werner KD, Comberg T, Kuebler P, Buttner HJ, Neumann FJ. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J. 2008;29:2859-67.
13. Routledge HC, Morice MC, Lefevre T, Garot P, De Marco F, Vaquerizo B, Louvard Y. 2-year outcome of patients treated for bifurcation coronary disease with provisional side branch T-stenting using drug-eluting stents. JACC Cardiovasc Interv. 2008;1:358-65.
14. Tsuchida K, Colombo A, Lefevre T, Oldroyd KG, Guetta V, Guagliumi G, von Scheidt W, Ruzyllo W, Hamm CW, Bressers M, Stoll HP, Wittebols K, Donohoe DJ, Serruys PW. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J. 2007;28:433-42. (Pubitemid 47343573)
15. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemela M, Kervinen K, Jensen JS, Galloe A, Nikus K, Vikman S, Ravkilde J, James S, Aaroe J, Ylitalo A, Helqvist S, Sjogren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation. 2006;114:1955-61. (Pubitemid 44665390)
16. Colombo A MJ, Morice MC, Ludwig J, Holmes DR, Spanos V, Louvard Y, Desmedt B, Di Mario C, Leon MB. Randomized study to evaluate sirolimus eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244-49. (Pubitemid 38372783)
17. Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D, Delgado A, Ojeda S, Melian F, Herrador J, Urena I, Burgos L. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J. 2004;148:857-64.
18. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A, Premchand RK, Guillard N, Piechaud JF. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv. 2000;49:274-83. (Pubitemid 30133517)
19. Lefevre T, Ormiston J, Guagliumi G, Schultheiss HP, Quilliet L, Reimers B, Brunel P, Wijns W, Buettner HJ, Hartmann F, Veldhof S, Miquel K, Su X, van der Giessen WJ. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. J Am Coll Cardiol. 2005;46:592-8. (Pubitemid 41132683)
20. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-51. (Pubitemid 46685903)